chronic lymphocytic leukaemia
TG Therapeutics completes FDA filing for Roche challenger in CLL
Richard Staines
blood cancer, chronic lymphocytic leukaemia, Roche, TG Therapeutics
0 Comment
NICE backs AZ’s Calquence for new use in leukaemia
Phil Taylor
AstraZeneca, Calquence, cholesterol, chronic lymphocytic leukaemia, Daiichi Sankyo, NHS, NICE, Nilemdo
0 Comment
AZ says Calquence is a safer drug than Imbruvica
Phil Taylor
AbbVie, AstraZeneca, BTK inhibitor, Calquence, chronic lymphocytic leukaemia, Imbruvica, Johnson & Johnson, Oncology
0 Comment
TG Therapeutics raises funds for cancer combination drug
Richard Staines
chronic lymphocytic leukaemia, Oncology, TG Therapeutics
0 Comment
CLL patients in England to get AZ’s Calquence after okay from NICE
Richard Staines
AstraZeneca, chronic lymphocytic leukaemia, market access, NICE
0 Comment
TG Therapeutics challenges Roche with FDA filing for CLL drug
Richard Staines
blood cancer, chronic lymphocytic leukaemia, CLL, fda, Roche, TG Therapeutics
0 Comment
Market Access/ News/ News/ Top stories
NICE backs chemo-free CLL combination from AbbVie and Roche
Richard Staines
AbbVie, cancer, chronic lymphocytic leukaemia, market access, Roche
0 Comment
Market Access/ News/ News/ News/ Oncology
AbbVie, J&J embed Imbruvica deeper in CLL therapy with new approval
Phil Taylor
AbbVie, chronic lymphocytic leukaemia, Imbruvica, Johnson & Johnson, Oncology
0 Comment